These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

554 related articles for article (PubMed ID: 17456574)

  • 81. Routine method for the simultaneous quantification of 17alpha-hydroxyprogesterone, testosterone, dehydroepiandrosterone, androstenedione, cortisol, and pregnenolone in human serum of neonates using gas chromatography-mass spectrometry.
    Magnisali P; Dracopoulou M; Mataragas M; Dacou-Voutetakis A; Moutsatsou P
    J Chromatogr A; 2008 Oct; 1206(2):166-77. PubMed ID: 18760785
    [TBL] [Abstract][Full Text] [Related]  

  • 82. The use of liquid chromatography-tandem mass spectrometry in newborn screening for congenital adrenal hyperplasia: improvements and future perspectives.
    de Hora M; Heather N; Webster D; Albert B; Hofman P
    Front Endocrinol (Lausanne); 2023; 14():1226284. PubMed ID: 37850096
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Comparison of basal and adrenocorticotropin-stimulated plasma 21-deoxycortisol and 17-hydroxyprogesterone values as biological markers of late-onset adrenal hyperplasia.
    Fiet J; Gueux B; Gourmelen M; Kuttenn F; Vexiau P; Couillin P; Pham-Huu-Trung MT; Villette JM; Raux-Demay MC; Galons H
    J Clin Endocrinol Metab; 1988 Apr; 66(4):659-67. PubMed ID: 2831244
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Limitations of 17-hydroxyprogesterone in investigating neonatal hyponatraemia.
    Ismail AA; Cawood M; Ufodiama EB; Jones ST
    Ann Clin Biochem; 2004 May; 41(Pt 3):245-7. PubMed ID: 15117442
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Rapid monitoring assay of congenital adrenal hyperplasia with microbore high-performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots.
    Lai CC; Tsai CH; Tsai FJ; Lee CC; Lin WD
    Rapid Commun Mass Spectrom; 2001; 15(22):2145-51. PubMed ID: 11746879
    [TBL] [Abstract][Full Text] [Related]  

  • 86. LC-MS/MS improves screening towards 21-hydroxylase deficiency.
    Ambroziak U; Kępczyńska-Nyk A; Kuryłowicz A; Wysłouch-Cieszyńska A; Małunowicz EM; Bartoszewicz Z; Kondracka A; Jaźwiec R; Pawłowska E; Szcześniak M; Dadlez M; Bednarczuk T
    Gynecol Endocrinol; 2015 Apr; 31(4):296-300. PubMed ID: 25539143
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Plasma 21-deoxycortisone: a sensitive additive tool in 21-hydroxylase deficiency in newborns.
    Fiet J; Bachelot G; Sow C; Farabos D; Helin N; Eguether T; Dufourg MN; Bellanne-Chantelot C; Ribaut B; Bachelot A; Young J; Houang M; Lamazière A
    Eur J Endocrinol; 2024 Aug; 191(2):204-210. PubMed ID: 39137138
    [TBL] [Abstract][Full Text] [Related]  

  • 88. LC-MS/MS based determination of basal- and ACTH-stimulated plasma concentrations of 11 steroid hormones: implications for detecting heterozygote CYP21A2 mutation carriers.
    Kulle AE; Riepe FG; Hedderich J; Sippell WG; Schmitz J; Niermeyer L; Holterhus PM
    Eur J Endocrinol; 2015 Oct; 173(4):517-24. PubMed ID: 26315375
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Monitoring congenital adrenal hyperplasia using blood spot 17-hydroxyprogesterone assay.
    Santos CM; Abad LR; Cua SC; Domingo CF
    Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():174-8. PubMed ID: 15906729
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Prenatal diagnosis of 21-hydroxylase deficiency congenital adrenal hyperplasia by simultaneous radioimmunoassay of 21-deoxycortisol and 17-hydroxyprogesterone in amniotic fluid.
    Gueux B; Fiet J; Couillin P; Raux-Demay MC; Mornet E; Galons H; Villette JM; Boue J; Dreux C
    J Clin Endocrinol Metab; 1988 Mar; 66(3):534-7. PubMed ID: 3258316
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Outcome of Newborn Screening for Congenital Adrenal Hyperplasia at Two Time Points.
    Eshragh N; Doan LV; Connelly KJ; Denniston S; Willis S; LaFranchi SH
    Horm Res Paediatr; 2020; 93(2):128-136. PubMed ID: 32659761
    [TBL] [Abstract][Full Text] [Related]  

  • 92. 17-Hydroxyprogesterone in children, adolescents and adults.
    Honour JW
    Ann Clin Biochem; 2014 Jul; 51(Pt 4):424-40. PubMed ID: 24711560
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Confirmation of congenital adrenal hyperplasia by adrenal steroid profiling of filter paper dried blood samples using ultra-performance liquid chromatography-tandem mass spectrometry.
    Rossi C; Calton L; Brown HA; Gillingwater S; Wallace AM; Petrucci F; Ciavardelli D; Urbani A; Sacchetta P; Morris M
    Clin Chem Lab Med; 2011 Apr; 49(4):677-84. PubMed ID: 21288182
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Salivary and plasma androstenedione and 17-hydroxyprogesterone levels in congenital adrenal hyperplasia.
    Otten BJ; Wellen JJ; Rijken JC; Stoelinga GB; Benraad TJ
    J Clin Endocrinol Metab; 1983 Dec; 57(6):1150-4. PubMed ID: 6605355
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening.
    Liu SY; Lee CT; Tung YC; Chien YH; Hwu WL; Tsai WY
    J Formos Med Assoc; 2018 Feb; 117(2):126-131. PubMed ID: 28392195
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Changing perspectives in screening for congenital hypothyroidism and congenital adrenal hyperplasia.
    Mitchell ML; Hsu HW; Sahai I
    Curr Opin Endocrinol Diabetes Obes; 2014 Feb; 21(1):39-44. PubMed ID: 24275619
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Rapid screening assay of congenital adrenal hyperplasia by measuring 17 alpha-hydroxyprogesterone with high-performance liquid chromatography/electrospray ionization tandem mass spectrometry from dried blood spots.
    Lai CC; Tsai CH; Tsai FJ; Wu JY; Lin WD; Lee CC
    J Clin Lab Anal; 2002; 16(1):20-5. PubMed ID: 11835526
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Newborn screening for congenital adrenal hyperplasia in Cuba: six years of experience.
    González EC; Carvajal F; Frómeta A; Arteaga AL; Castells EM; Espinosa T; Coto R; Pérez PL; Tejeda Y; Del Río L; Segura MT; Almenares P; Robaina R; Fernández JL
    Clin Chim Acta; 2013 Jun; 421():73-8. PubMed ID: 23481450
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The actual incidence of congenital adrenal hyperplasia in Brazil may not be as high as inferred--an estimate based on a public neonatal screening program in the state of Goiás.
    Silveira EL; dos Santos EP; Bachega TA; van der Linden Nader I; Gross JL; Elnecave RH
    J Pediatr Endocrinol Metab; 2008 May; 21(5):455-60. PubMed ID: 18655527
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Diagnosis of congenital adrenal hyperplasia by rapid determination of 17alpha-hydroxyprogesterone in dried blood spots by gas chromatography/mass spectrometry following microwave-assisted silylation.
    Deng C; Ji J; Zhang L; Zhang X
    Rapid Commun Mass Spectrom; 2005; 19(20):2974-8. PubMed ID: 16178052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.